Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

BACKGROUND: Treatment for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is improving but not benefiting individuals unaware to be infected. To inform screening policies we assessed (1) the hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus antibody (anti-HCV-Ab) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahné, Susan JM, Veldhuijzen, Irene K, Wiessing, Lucas, Lim, Tek-Ang, Salminen, Mika, Laar, Marita van de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716892/
https://www.ncbi.nlm.nih.gov/pubmed/23597411
http://dx.doi.org/10.1186/1471-2334-13-181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716892/
https://www.ncbi.nlm.nih.gov/pubmed/23597411
http://dx.doi.org/10.1186/1471-2334-13-181

Ejemplares similares